S&P 500: 669.03 +1.0% NASDAQ 100: 600.38 +1.1% Dow Jones: 470.30 +0.8%

Joel Greenblatt’s KRYS Holdings & Trades

First Buy
Q1 2025
Duration Held
4 Quarters
Largest Add
Q1 2025
+4,804 Shares
Current Position
1,303 Shares
$321,242 Value

Joel Greenblatt's KRYS Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 1,303 shares of Krystal Biotech, Inc. (KRYS) worth $321,242, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.

Based on 13F filings, Joel Greenblatt has maintained this position in KRYS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 1,307 shares. Largest reduction occurred in Q2 2025, reducing 4,804 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's Krystal Biotech (KRYS) Holding Value Over Time

Track share changes against reported price movement

Quarterly Krystal Biotech (KRYS) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -4 Reduce 0.31% 1,303 $246.54
Q3 2025 +1,307 New Buy 1,307 $176.53
Q2 2025 -4,804 Sold Out 0 $0.00
Q1 2025 +4,804 New Buy 4,804 $180.30

Joel Greenblatt's Krystal Biotech Investment FAQs

Joel Greenblatt first purchased Krystal Biotech, Inc. (KRYS) in Q1 2025, acquiring 4,804 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held Krystal Biotech, Inc. (KRYS) for 4 quarters since Q1 2025.

Joel Greenblatt's largest addition to Krystal Biotech, Inc. (KRYS) was in Q1 2025, adding 4,804 shares worth $866,161.

According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 1,303 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $321,242.

As of the Q4 2025 filing, Krystal Biotech, Inc. (KRYS) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in Krystal Biotech, Inc. (KRYS) was 4,804 shares, as reported at the end of Q1 2025.